612 related articles for article (PubMed ID: 22137982)
1. Timing of fertility preservation procedures in a cohort of female patients with cancer.
Jenninga E; Louwe LA; Peters AA; Nortier JW; Hilders CG
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):170-3. PubMed ID: 22137982
[TBL] [Abstract][Full Text] [Related]
2. Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation.
Baynosa J; Westphal LM; Madrigrano A; Wapnir I
J Am Coll Surg; 2009 Nov; 209(5):603-7. PubMed ID: 19854400
[TBL] [Abstract][Full Text] [Related]
3. Female fertility preservation: practical and ethical considerations of an underused procedure.
Jenninga E; Hilders CG; Louwe LA; Peters AA
Cancer J; 2008; 14(5):333-9. PubMed ID: 18836340
[TBL] [Abstract][Full Text] [Related]
4. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
5. Techniques for fertility preservation in patients with breast cancer.
Dunn L; Fox KR
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):68-73. PubMed ID: 19125006
[TBL] [Abstract][Full Text] [Related]
6. [Oocyte/embryo cryopreservation before chemotherapy for breast cancer].
Decanter C; Gligorov J
Gynecol Obstet Fertil; 2011 Sep; 39(9):501-3. PubMed ID: 21835668
[TBL] [Abstract][Full Text] [Related]
7. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
Decanter C; Robin G
Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
[TBL] [Abstract][Full Text] [Related]
8. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.
Das M; Shehata F; Son WY; Tulandi T; Holzer H
Hum Reprod; 2012 Aug; 27(8):2509-14. PubMed ID: 22617122
[TBL] [Abstract][Full Text] [Related]
9. Preservation of fertility in females with haematological malignancy.
Donnez J; Dolmans MM
Br J Haematol; 2011 Jul; 154(2):175-84. PubMed ID: 21564077
[TBL] [Abstract][Full Text] [Related]
10. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
[TBL] [Abstract][Full Text] [Related]
11. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.
Azim AA; Costantini-Ferrando M; Oktay K
J Clin Oncol; 2008 Jun; 26(16):2630-5. PubMed ID: 18509175
[TBL] [Abstract][Full Text] [Related]
12. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
[TBL] [Abstract][Full Text] [Related]
13. Strategies for fertility preservation in young early breast cancer patients.
Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
[TBL] [Abstract][Full Text] [Related]
14. [Breast cancer and fertility: critical review, considerations and perspectives].
This P
Bull Cancer; 2008 Jan; 95(1):17-25. PubMed ID: 18230566
[TBL] [Abstract][Full Text] [Related]
15. Fertility preservation in young women undergoing breast cancer therapy.
Sonmezer M; Oktay K
Oncologist; 2006 May; 11(5):422-34. PubMed ID: 16720842
[TBL] [Abstract][Full Text] [Related]
16. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
17. Controversies in preservation of ovary function and fertility in patients with breast cancer.
Gerber B; Dieterich M; Müller H; Reimer T
Breast Cancer Res Treat; 2008 Mar; 108(1):1-7. PubMed ID: 17457668
[TBL] [Abstract][Full Text] [Related]
18. Fertility sparing in cancer patients.
Bouchlariotou S; Tsikouras P; Benjamin R; Neulen J
Minim Invasive Ther Allied Technol; 2012 Jul; 21(4):282-92. PubMed ID: 21919808
[TBL] [Abstract][Full Text] [Related]
19. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents.
Roness H; Kalich-Philosoph L; Meirow D
Hum Reprod Update; 2014; 20(5):759-74. PubMed ID: 24833728
[TBL] [Abstract][Full Text] [Related]
20. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
